POZ October-November 2012

POZ October-November 2012

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:



POZ Magazine

The Show Must Go On

Broadway Cares/Equity Fights AIDS supports nearly 400 HIV and family service programs nationwide, as well as AIDS research and advocacy.

POZ October/November 2012 Quilt Images

A Capital Affair

Science suggests that it’s possible for us to start to end AIDS.

From the Editor

POZ Magazine

Trench Warfare

The key message I hoped to hear at the XIX International AIDS Conference in Washington, DC, did in fact ring through loud and clear.


POZ Magazine

Letters- October/November 2012

Françoise Barré-Sinoussi’s last remark was on the need for innovation, multidisciplinary collaboration and funding.


POZ Magazine

Full-Court Press

Scott A. Schoettes of Lambda Legal outlines the battle being waged in U.S. courts over HIV criminalization.

What You Need to Know

POZ Magazine

Jamar Rogers’s Voice Will Go On

We haven’t heard the last of Jamar Rogers, the HIV-positive former meth addict who captured America’s hearts and ears on The Voice.

POZ Magazine

Olympic Winner Tells the World He’s Positive

The summer Olympics inspired awe among billions. For gay Australian Olympian Ji Wallace, they inspired a public disclosure that he has HIV.

POZ Magazine

Pesky Email Spam Offers Clues for Eradicating HIV

David Heckerman, the guy who invented Microsoft’s email spam filter, is now fighting another type of invader: HIV.

POZ Magazine

Infant Circumcision Grows to Global Debate

The health benefits of circumcising baby boys outweigh the risks, the American Academy of Pediatrics says in an updated policy statement.

POZ Magazine

Why Folks With HIV Can Be Excellent Transplant Recipients

Appearing on 
a July episode of the ABC medical documentary series NY Med, John Rankl inspired and educated millions by sharing that he...

We Hear You

POZ Magazine

Dr. No

A case of HIV discrimination by a medical practitioner made national headlines recently when a New Jersey man living with HIV sued a Catholic...

POZ Survey Says

POZ Magazine

Taking Risks to Help Others

All HIV-positive people alive today because of their meds owe a bit of gratitude to yesterday’s clinical trial volunteers.

What Matters to You

POZ Magazine

Finding an HIV Vaccine

While HIV meds can keep positive people healthy and simultaneously lower their risk of spreading the virus, too few people have access to trea...

Treatment News

POZ Magazine

Detecting the Missing Link Between HIV and Brain Drain

Researchers at Georgetown University Medical Center have released data that HIV interferes with a protein that supports brain function.

POZ Magazine

Point of Reentry: Getting Prisoners HIV Care

For the estimated 2 percent of prisoners in this country who are living with HIV/AIDS, release from prison brings challenges—finding hou...

POZ Magazine

New Booster in Town: Cobicistat

Cobicistat, a new pharmacokinetic (PK) enhancer from Gilead Sciences, is set to unseat Abbott’s Norvir (ritonavir) as the only approved...

POZ Magazine

Bronx Cheer: An HIV Testing Program Shows Progress

In a New York City borough hard hit by HIV, a city health department program is putting a dent in the epidemic.

POZ Magazine

The “War on Drugs” Spreads HIV

The global war on drugs is driving the HIV/AIDS pandemic.

Comfort Zone

POZ Magazine

Dear Diary

Whether you’re grappling with a temporary frustration or an ongoing sense of anger or sadness, the act of writing about your negative feelings...

POZ Heroes

POZ Magazine

Hip-Hop Soul

When Kathleen Adams, a student at Fordham University in the Bronx, New York, surveyed the way women of color were portrayed in mainstream medi...


Hot topics

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.